TriMoVac

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTriMoVac
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll-like receptor agonistsProtein kinases inhibitors
TargetsToll-like receptorProtein kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrinity College Dublin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTriMod Therapeutics LtdTrinity College Dublin
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A